株式会社フェニックス

What 株式会社フェニックス does

株式会社フェニックス (Phoenix Corporation) is a privately-held Japanese medical device trading company specializing in blood purification systems and vascular access interventions, headquartered in Kariya City, Aichi Prefecture. Founded in 1974 and converted to a stock company in 2001, the firm operates three offices across the Tokai region (Kariya HQ, Nagoya, Higashimikawa) and serves national, public, and university hospitals as well as municipal and private dialysis centers. Its core product portfolio centers on the Resolution family of vasodilatation catheters (Resolution, Resolution SD, Resolution 35) for dialysis access maintenance, a private-label cleaning agent series (Chelat-er®) for dialysis machines, and a broad catalogue of blood purification systems covering HD, HF, HDF, CDF, CHDF, CAPD, DHP, PE, DFPP, PP, and IAPP modalities, supplemented by urology devices (ESWL lithoclast, BPH treatment) and angiography equipment.

The company functions as a specialist dealer rather than a manufacturer, generating revenue through one-time sales of medical equipment and consumables to hospitals and clinics across the Tokai region. Its go-to-market is sales-led and face-to-face, leveraging direct hospital visits, academic conference participation, and content marketing via its corporate website to build long-cycle trust relationships. Service offerings extend beyond product supply to include inventory management, information provision, and consulting support for new dialysis center establishment (planning, construction, staffing, and operations). Specific reference customers include major public hospitals, the Tokai Regional Artificial Kidney Center, Kobe Tokushukai Hospital (Cardiovascular Surgery), and Toyohashi Meitsu Clinic, with named clinicians contributing case-study materials.

Phoenix reported sales of 3 billion JPY in FY2015 and currently operates with approximately 28 employees. The firm is led by Representative Director Shinkai Masahiko (新開昌彦). No parent company, external institutional investors, public listing, M&A activity, or disclosed funding rounds are present in the available data. The company is not currently recruiting and has no disclosed AI/ML capabilities, patents, or regulatory actions in the source material.

Name

株式会社フェニックス

Legal name

株式会社フェニックス

Website

https://ac-phoenix.co.jp

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

11–50 employees

Short description

株式会社フェニックス is a Tokai-region, Japan-based specialist medical device trading company founded in 1974, distributing blood purification systems, the Resolution family of vasodilatation catheters, and dialysis equipment to public, university, and municipal hospitals through a face-to-face sales model.

Ownership category

akta.pro rank

Headquarters

HQ city

刈谷市

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. 医療機器・医療材料販売: 血液浄化システム関連機器・耗材、血管アクセスデバイス、泌尿器科機器などの医療機器・医療材料的销售を通じて収益を上げている。

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

株式会社フェニックス is a specialized medical device trading company (専門商社) that distributes blood purification systems, vascular access intervention devices (including the proprietary Resolution family of vascular dilatation catheters), urology equipment, angiography devices, and dialysis consumables to medical institutions. The company provides a holistic one-stop supply of medical materials, equipment, systems, and information, with face-to-face direct sales support to doctors, nurses, and medical engineers at national hospitals, university hospitals, municipal blood purification centers, and urology centers.

Product overview

株式会社フェニックス is a specialized medical device trading company (血液浄化システム専門商社) that serves as a blood purification system specialist dealer. The company operates as a business solutions provider supporting medical professionals (doctors, nurses, medical engineers) in providing quality medical care. The product portfolio centers on three key areas: (1) Vascular access intervention products including the Resolution family of vasodilatation catheters (Resolution, Resolution SD, Resolution 35) designed for dialysis access maintenance; (2) Comprehensive blood purification systems covering HD, HF, HDF, CDF, CHDF, CAPD, DHP, PE, DFPP, PP, and IAPP treatment modalities; and (3) Supporting medical equipment including urology devices (ESWL LITHOCLAST, BPH treatments) and angiography equipment. The company also provides the Shunt-110 intervention support service leveraging 30 years of dialysis expertise, and distributes the Chelat-er® cleaning agent series for dialysis equipment maintenance. Rather than manufacturing, the company functions as a specialized dealer offering product proposals, the latest medical information, inventory management services, and consulting support for dialysis center establishment.

Differentiator

Problem solved

Functional benefit

Brands

• Resolution: General standard type vascular dilation catheter for GW0.018inch/5F sheath, used in dialysis access treatment
• Resolution SD
• Resolution35

Products and services

• Resolution Vascular Dilatation Catheter General standard type vascular dilatation catheter featuring a long tapered chip and firm shaft for improved passage through curved and tortuous blood vessels and anastomoses. Compatible with GW 0.018 inch and 5F sheath. Designed for vascular access interventions in dialysis patients.
• Resolution SD Vascular Dilatation Catheter Special-type vascular dilatation catheter with 15mm long tapered tip and firm shaft enabling smooth passage through bent, tortuous vessels and anastomoses. Compatible with GW 0.018 inch and 4F sheath. Features high-pressure polyamide balloon with low compliance to prevent over-dilation of normal vessel segments.
• Resolution 35 Vascular Dilatation Catheter Vascular dilatation catheter with 15mm long tapered chip design for improved anastomotic passage and crossability. Features 0.035 inch guide wire compatibility and high-pressure polyamide balloon with controlled compliance to prevent over-dilation of normal vessel segments. Designed for dialysis access treatment.
• Chelat-er® Cleaning Agent Series Cleaning agent series designed for use with artificial dialysis equipment. Used by dialysis centers for the maintenance and cleaning of dialysis machines.

Quantifiable outcome

• 患者さんにQOLの高い医療サービスが提供できるよう支援

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves9 records

Expansion highlights4 records

Broad incumbents

• スズケン (Suzuken): One of Japan's largest pharmaceutical and medical device wholesalers, distributing to hospitals and pharmacies nationwide. Overlaps with Phoenix in medical device distribution but operates at national wholesaler scale with broader product categories.
• Baxter International: Global medical products company with a significant dialysis and blood purification portfolio, including continuous renal replacement therapy (CRRT) and peritoneal dialysis. Comparable end-market but vastly broader product portfolio and global scale.
• Fresenius Medical Care: Global leader in dialysis products and services, operating dialysis centers and manufacturing dialyzers, machines, and related devices. Addresses the same end-customer needs as Phoenix but at a global integrated scale.
• JMS Co., Ltd. Established Japanese medical device manufacturer with a strong dialysis and blood purification portfolio, including dialyzers and infusion products. Overlaps with Phoenix's customer-facing role but operates at manufacturer scale with broader product lines.
• 旭化成メディカル (Asahi Kasei Medical): Leading Japanese manufacturer of artificial kidneys (dialyzers) and blood purification devices. Serves the same end customers (blood purification centers) as Phoenix but as an upstream product manufacturer rather than distributor.
• 川澄化学工業 (Kawasumi Laboratories): Japanese medical device manufacturer specializing in artificial kidneys, blood tubing sets, and dialysis accessories. Overlaps with Phoenix's distribution focus on blood purification consumables but at the manufacturing tier.
• アルフレッサ (Alfresa): Major Japanese pharmaceutical and medical device wholesaler serving hospitals, clinics, and pharmacies across Japan. Comparable in medical device distribution channel role but with significantly larger scale and broader product coverage.
• ニプロ (Nipro): Major Japanese medical device manufacturer with a comprehensive dialysis product portfolio including dialyzers, blood lines, and related consumables. Comparable end-market exposure in blood purification, though operating at manufacturer scale.
• 東レ・メディカル (Toray Medical): Subsidiary of Toray Industries focused on dialysis membranes and blood purification products. Serves the same Japanese dialysis customer base as Phoenix, but as a major membrane and equipment manufacturer.

Direct peers

• 村中医療器: Japanese regional medical equipment wholesaler with a similar specialist dealer model, distributing medical devices and supplies to hospitals and clinics across multiple regions of Japan. Directly comparable as a regional trading company focused on medical devices.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE%E3%83%95%E3%82%A7%E3%83%8B%E3%83%83%E3%82%AF%E3%82%B9

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 株式会社フェニックス